Introduction Post-Approval Changes for Approved Biosimilars require a structured, science-driven comparability assessment conducted in accordance with the ICH Q5E framework … Continue reading Post-Approval Changes for Approved Biosimilars: Comparability Requirements Under ICH Q5E